HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 257 filers reported holding HERBALIFE LTD in Q4 2020. The put-call ratio across all filers is 2.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $770,000 | -4.5% | 18,822 | -1.1% | 0.01% | -9.1% |
Q3 2021 | $806,000 | -25.2% | 19,022 | -6.9% | 0.01% | -21.4% |
Q2 2021 | $1,077,000 | +41.2% | 20,422 | +18.6% | 0.01% | +27.3% |
Q1 2021 | $763,000 | -11.9% | 17,222 | -4.4% | 0.01% | -8.3% |
Q4 2020 | $866,000 | +6.0% | 18,022 | +2.9% | 0.01% | -14.3% |
Q3 2020 | $817,000 | -5.5% | 17,522 | -8.8% | 0.01% | -12.5% |
Q2 2020 | $865,000 | +57.0% | 19,222 | +1.6% | 0.02% | +33.3% |
Q1 2020 | $551,000 | -38.9% | 18,922 | 0.0% | 0.01% | -25.0% |
Q4 2019 | $902,000 | +22.6% | 18,922 | -2.6% | 0.02% | +14.3% |
Q3 2019 | $736,000 | -12.3% | 19,422 | -1.0% | 0.01% | -12.5% |
Q2 2019 | $839,000 | -22.7% | 19,622 | -4.2% | 0.02% | -27.3% |
Q1 2019 | $1,086,000 | -8.9% | 20,481 | +1.2% | 0.02% | -18.5% |
Q4 2018 | $1,192,000 | +8.6% | 20,230 | +0.5% | 0.03% | +28.6% |
Q3 2018 | $1,098,000 | -3.8% | 20,130 | -5.2% | 0.02% | -12.5% |
Q2 2018 | $1,141,000 | -2.1% | 21,230 | +77.4% | 0.02% | -4.0% |
Q1 2018 | $1,166,000 | +44.0% | 11,965 | 0.0% | 0.02% | +47.1% |
Q4 2017 | $810,000 | -4.9% | 11,965 | -4.8% | 0.02% | -10.5% |
Q3 2017 | $852,000 | -5.0% | 12,565 | 0.0% | 0.02% | -9.5% |
Q2 2017 | $897,000 | +14.6% | 12,565 | -6.7% | 0.02% | +10.5% |
Q1 2017 | $783,000 | +20.6% | 13,465 | 0.0% | 0.02% | +18.8% |
Q4 2016 | $649,000 | -21.7% | 13,465 | +0.7% | 0.02% | -23.8% |
Q3 2016 | $829,000 | +5.9% | 13,365 | 0.0% | 0.02% | 0.0% |
Q2 2016 | $783,000 | -2.6% | 13,365 | +2.3% | 0.02% | -4.5% |
Q1 2016 | $804,000 | +14.9% | 13,065 | 0.0% | 0.02% | +15.8% |
Q4 2015 | $700,000 | -1.7% | 13,065 | 0.0% | 0.02% | -5.0% |
Q3 2015 | $712,000 | -0.3% | 13,065 | +0.8% | 0.02% | +5.3% |
Q2 2015 | $714,000 | +24.0% | 12,965 | -3.7% | 0.02% | +26.7% |
Q1 2015 | $576,000 | +14.3% | 13,465 | +0.7% | 0.02% | +7.1% |
Q4 2014 | $504,000 | -13.8% | 13,365 | 0.0% | 0.01% | -17.6% |
Q3 2014 | $585,000 | -35.5% | 13,365 | -5.0% | 0.02% | -34.6% |
Q2 2014 | $907,000 | +3.7% | 14,065 | -7.9% | 0.03% | +4.0% |
Q1 2014 | $875,000 | -26.7% | 15,265 | +0.7% | 0.02% | -28.6% |
Q4 2013 | $1,194,000 | +12.9% | 15,165 | 0.0% | 0.04% | +2.9% |
Q3 2013 | $1,058,000 | +53.6% | 15,165 | -0.7% | 0.03% | +47.8% |
Q2 2013 | $689,000 | – | 15,265 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |